Status:
COMPLETED
Bispectral Index Throughout Esophageal Cancer Operation
Lead Sponsor:
Samsung Medical Center
Conditions:
Esophageal Cancer
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The investigators try to conduct a study to assess the impact of changing patients' lateral decubitus position on BIS readings during esophageal cancer operation. Also, the investigators evaluate the ...
Detailed Description
Bispectral index (BIS) was developed to monitor a patient's level of consciousness under general anesthesia. Several factors have been found to alter BIS readings without affecting the depth of anesth...
Eligibility Criteria
Inclusion
- the patients who are planned the esophageal cancer operation
Exclusion
- patient who has dermatitis
- patient who refuse to participate in this study
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 3 2018
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03397745
Start Date
January 15 2018
End Date
August 3 2018
Last Update
September 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung medical center
Seoul, South Korea, 06351